News about

Lupin's Pithampur Unit-1 facility receives EIR from U.S. FDA

Lupin's Pithampur Unit-1 facility receives EIR from U.S. FDA

Pharma major Lupin Limited (Lupin) today announced the receipt of the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (U.S. FDA) for its Pithampur Unit-1, India facility. The inspection for the facility was conducted by the U.S. FDA between February 3, 2020 and February 11, 2020

| 30/04/2020 | By 523

Virtual Show: new technologies for solid dosage forms from Syntegon

Virtual Show: new technologies for solid dosage forms from Syntegon

From May 7 to 13, Syntegon Technology showcases its long-standing processing and packaging expertise for solid dosage forms at the Virtual Show. The new Sepion coater series, which is available in six sizes, marks the beginning of the novelties

| 29/04/2020 | By 438

Hydroxychloroquine and Chloroquine Marketto more than Double in 2020 ? TechSci Research

Hydroxychloroquine and Chloroquine Marketto more than Double in 2020 ? TechSci Research

Increase in prevalence of COVID-19 to drive demand for hydroxychloroquine and chloroquine across the globe

| 29/04/2020 | By 184

IIT Guwahati collaborates with Hester Biosciences Limited to develop vaccine against COVID-19

IIT Guwahati collaborates with Hester Biosciences Limited to develop vaccine against COVID-19

Indian Institute of Technology Guwahati is collaborating with Hester Biosciences Limited, a pharmaceutical company based in Ahmedabad, Gujarat, to work on the vaccine development against COVID-19. The agreement between the two parties was signed on 15th April 2020

| 29/04/2020 | By 296

Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals

Syngene International opens COVID-19 RT-PCR testing centre to support Bengaluru hospitals

Syngene International Ltd., a global research and development services company, today announced the opening of a COVID-19 testing laboratory at its Bengaluru site. In less than six weeks, the company used its expertise in clinical trial management

| 28/04/2020 | By 727

Revive Therapeutics gets US FDA recommendation tostart phase 3 trial of Bucillamine to treat COVID-19

Revive Therapeutics gets US FDA recommendation tostart phase 3 trial of Bucillamine to treat COVID-19

Revive Therapeutics, a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, announced that it has received positive feedback from the US Food and Drug Administration (FDA) in response to the company's Pre-Investigational New Drug (pre-IND) meeting

| 25/04/2020 | By 859

FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments

FDA Approves New Therapy for Triple Negative Breast Cancer That Has Spread, Not Responded to Other Treatments

Today, the U.S. Food and Drug Administration granted accelerated approval to Trodelvy (sacituzumab govitecan-hziy) for the treatment of adult patients with triple-negative breast cancer that has spread to other parts of the body. Patients must have received at least two prior therapies before taking Trodelvy

| 25/04/2020 | By 589

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

Bayer partners with Population Health Research Institute (PHRI) on global clinical research evaluating COVID-19 treatments

Bayer announced today its Canadian organization Bayer Inc., Mississauga, Ontario, will partner with the Population Health Research Institute (PHRI) in launching a major clinical research program aimed at identifying potential treatments against COVID-19

| 22/04/2020 | By 322

WHO issue new guidance on use of ferritin concentrations to assess iron deficiency and protect brain development

WHO issue new guidance on use of ferritin concentrations to assess iron deficiency and protect brain development

Detecting iron deficiency early during pregnancy and in young children is crucial. Iron deficiency in children under two years of age can have significant and irreversible effects on brain development. This can lead to negative consequences on learning and school performance later in life

| 22/04/2020 | By 398

Pune based companies develop ImmunoQuick Rapid COVID-19 TEST kit

Pune based companies develop ImmunoQuick Rapid COVID-19 TEST kit

Unlike ordinary antibody tests, ImmunoQuick Covid-19 test separates the two forms of antibodies IgM and IgG into separate bands. This has enormous advantages because clinicians can now separate patients into early infections, active patients and resolved/cured patients

| 21/04/2020 | By 1148

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members